Abstract
A generally accepted definition of chemoprevention is the administration of purified chemical agents for the prevention of clinical cancer. This concept is commonly thought to have emerged a little over two decades ago and is attributed to cancer biologists who were elucidating the role of various natural substances and pharmacologic agents on the stepwise progression of cancer.26 However, a brief review of public health and medical advances over the twentieth century will reveal that the concept and application of chemoprevention for various disease processes evolved directly from the great successes of nutritional scientists in the early decades of this century. Regardless of the conceptual origins of cancer chemoprevention, the progress in identifying agents, testing them in preclinical models, followed by human intervention studies, has rapidly accelerated in recent years. The century ends with the success of the Breast Cancer Prevention Trial (BCPT) illustrating the ability of the anti-estrogen Tamoxifen to prevent breast cancer in a cohort of women at high-risk.10 Indeed, it is our opinion that chemoprevention, tobacco control, and the application of early detection strategies provide the opportunity to reduce cancer mortality by at least 50% within a generation.11 The objective of this review is to provide the broad audience of cancer prevention investigators with a brief overview of the progress and future promise of cancer chemoprevention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Institute for Cancer Research. Food Nutrition and the Prevention of Cancer: a Global Perspective Washington, DC: American Institute for Cancer Research 1997.
Anonymous. Iodine fortification and thyrotoxicosis. Nutr Rev 1970;28:212–214.
Anonymous. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992; 41:1–7.
Austin H, Keil JE, Cole P. A prospective follow-up study of cancer mortality in relation to serum DDT. Am J Public Health 1989; 79:43–46.
Bentley JR, Ferrini RL, Hill LL. American College of Preventive Medicine Public Policy Statement: Folic acid fortification of grain products in the U.S. to prevent neural tube defects. Am J Prey Med 1999;16:264–267.
Berry Rj, Li Z, Erickson JD, Li S, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999;341:1485–1490.
Clinton SK. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 1998;56: 35–51.
de la Chapelle A, Peltomaki P. Genetics of hereditary colon cancer. Annu Rev Genet 1995;29:329–348.
de la Chapelle A, Peltomaki P. The genetics of hereditary common cancers. Curr Opin Genet Dev 1998;8:298–303.
Fisher B, Costantino JP, Wickerham DL, Redmond CK, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371–1388.
Greenwald P, Kramer BS, Weed DL, eds. Cancer Prevention and Control. New York, NY: Marcel Dekker, 1995.
Hoar SK, Blair A, Holmes FF, Boysen CD, et al. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA 1986;256:1141–1147.
Holland JF, Bast RC, Morton DL, Frei E, et al. Cancer Medicine 4 th edition , Baltimore, MD: Williams and Wilkins, 1997.
Hollick MF, Shao Q, Liu WW, Chen TC. The vitamin D content of fortified milk and infant formula. N Engl J Med 1992; 326:1178–1181.
Johansson SL, Cohen SM. Epidemiology and etiology of bladder cancer. Semin Surg Oncol 1997; 13:291–298.
Kelloff GJ, Malone WF, Boone CW, Steele VE, Doody LA. Intermediate biomarkers of precancer and their application in chemoprevention. J Cell Biochem - Supplement 1992;16G:15–21.
Kimball OP, Marine D. The prevention of simple goiter in man. Arch Inst Med 1918; 22:41.
Lee K, Bradley R, Dwyer J, Lee SL. Too much versus too little: the implications of current iodine intake in the United States. Nutr Rev 1999;57:177–181.
Liotta LA. Probing the depths of degradation: matrix metaloproteinase-2 and endometrial menstrual breakdown. J Clin Invest 1996;97:273–274.
Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999;12:351–366.
Mertz W. Food fortification in the United States. Nutr Rev 1997; 55:44–49.
Mukherjee P, Sotnikov AV, Mangian HJ, Zhou J. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst 1999;91:512–523.
Schottenfield D, Fraumeni Jr. JF. Cancer Epidemiology and Prevention, New York, NY: Oxford University Press, 1996.
Sizer FS, Whitney EN. “The Vitamins” In: Nutrition Concepts and Controversies 7 th edition, Belmont, CA: West Wadsworth, 1997.
Solon FS, Fernandez TL, Latham MC, Popkin BM. Planning, implementation, and evaluation of a fortification program. Control of vitamin A deficiency in the Philippines. J Am Diet Assoc 1979;74:112–118.
Sporn MB. Combination chemoprevention of cancer. Nature 1980;287:107–108.
Tinger A, Wasserman TH, Klein EE, Miller EA, et al. The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys 1997; 37:865–870.
Toro O, de Pablo S, Aguayo M, Gattan V, et al. Prevention of vitamin A deficiency by fortification of sugar. A field study. Arch Latinoam Nutr 1977;27:169–179.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Miller, E.C., Liao, Z., Guo, Y., Shah, S.M., Clinton, S.K. (2001). Chemoprevention: Progress And Opportunity. In: Nutrition and Cancer Prevention. Advances in Experimental Medicine and Biology, vol 492. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1283-7_20
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1283-7_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5477-2
Online ISBN: 978-1-4615-1283-7
eBook Packages: Springer Book Archive